InfuSystem Holdings, Inc (INFU) Form 10-Q — May 8, 2026
InfuSystem Holdings, Inc. reported a decrease in net revenues of $1.0 million, or 3.0%, to $33.7 million for the three months ended March 31, 2026, compared to $34.7 million for the same period in 2025. This decrease was primarily due to lower net revenues in the Device Solutions segment, which saw a decline of $2.4 million, or 16.9%, to $11.6 million. The Patient Services segment, however, saw an increase in net revenues of $1.3 million, or 6.4%, to $22.1 million.
Key figures
- Eps
- 0.05
- Eps Beat
- 0.06
- Revenue
- 33684
- Net Income
- 1017
- Total Debt
- 19646
- Cash Position
- 2106
Price after filing
1 day: 0.0%7 days: +2.4%30 days: +8.4%
Close on the filing date to close N calendar days later (from $8.41). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.